James Edgemond | CFO |
Dr. Martine Rothblatt | Chairman and CEO |
Michael Benkowitz | President and COO |
Hartaj Singh | Oppenheimer & Company |
Jessica Fye | JP Morgan |
Liana Moussatos | Wedbush Securities |
Chris Shibutani | Cowen |
Martin Auster | Credit Suisse |
Good morning and welcome to the United Therapeutics Corporation Second Quarter 2019 Earnings Call. My name is Michelle and I will be your conference operator today. All participants will be in a listen-only mode until the question-and-answer portion of this earnings call. [Operator Instructions]
I will now turn the conference over to Mr.